Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Meng-Ran Lang"'
Autor:
Shao-Hua Ren, Zi-Lin Cui, Meng-Ran Lang, Qiang Li, Wei Zhang, Feng Fang, Qiang Wu, Yun-Long Cui, Hui-Kai Li, Ping Chen, Yamin Zhang, Tianqiang Song
Publikováno v:
J Gastrointest Oncol
BACKGROUND: Regorafenib is a standard 2nd-line treatment for patients with advanced hepatocellular carcinoma (HCC), but the efficacy and safety of sequential therapy with sorafenib and regorafenib among advanced HCC patients in China is not clear. ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08ab7bbe727bd5b4fb39042cb952bcf7
https://europepmc.org/articles/PMC9274072/
https://europepmc.org/articles/PMC9274072/
